Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Lakshmi B. Potluri"'
Autor:
Rao Prabhala, William E. Pierceall, Mehmet Samur, Lakshmi B. Potluri, Kevin Hong, Teresa Peluso, Srikanth Talluri, Angela Wang, Aishwarya Katiki, Sahan D. Vangala, Michael Buonopane, Vaishnavi Bade, Hannah Seah, Arthur Krogman, Sanika Derebail, Mariateresa Fulciniti, Suzan B. Lazo, Paul Richardson, Kenneth Anderson, Jill Corre, Herve Avet-Loiseau, Anjan Thakurta, Nikhil Munshi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundMultiple Myeloma (MM) patients exhibit dysregulated immune system, which is further weakened by chemotherapeutic agents. While cereblon-modulating agents, such as pomalidomide and lenalidomide, have been found to improve the immune profile,
Externí odkaz:
https://doaj.org/article/ec54f456dc72424aa10934daa1704895
Autor:
Srikanth Talluri, Mehmet K. Samur, Leutz Buon, Subodh Kumar, Lakshmi B. Potluri, Jialan Shi, Rao H. Prabhala, Masood A. Shammas, Nikhil C. Munshi
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-11 (2021)
Abstract Multiple myeloma (MM) is a heterogeneous disease characterized by significant genomic instability. Recently, a causal role for the AID/APOBEC deaminases in inducing somatic mutations in myeloma has been reported. We have identified APOBEC/AI
Externí odkaz:
https://doaj.org/article/d13895ee298b46c692921d6655cf5d13
Autor:
Shidai Mu, Srikanth Talluri, Jiangning Zhao, Lai Shi, Hannah Seah, Lakshmi B. Potluri, Jialan Shi, Mehmet K. Samur, Masood A. Shammas, Nikhil C Munshi
Publikováno v:
Blood. 140:4196-4197
Autor:
Subodh Kumar, Srikanth Talluri, Jiangning Zhao, Chengcheng Liao, Lakshmi B. Potluri, Leutz Buon, Shidai Mu, Jialan Shi, Chandraditya Chakraborty, Yu-Tzu Tai, Mehmet K. Samur, Masood A. Shammas, Nikhil C. Munshi
Genomic instability contributes to cancer progression and is at least partly due to dysregulated homologous recombination. Here, we show that an elevated level of ABL1 kinase overactivates the HR pathway and causes genomic instability in multiple mye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e61bb7108900da5a003b644b297d1d
https://doi.org/10.1101/2022.05.12.491727
https://doi.org/10.1101/2022.05.12.491727
Autor:
Subodh Kumar, Rao Prabhala, Jialan Shi, Masood A. Shammas, Lakshmi B. Potluri, Srikanth Talluri, Leutz Buon, Nikhil C. Munshi, Mehmet Kemal Samur
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-11 (2021)
Blood Cancer Journal
Blood Cancer Journal
Multiple myeloma (MM) is a heterogeneous disease characterized by significant genomic instability. Recently, a causal role for the AID/APOBEC deaminases in inducing somatic mutations in myeloma has been reported. We have identified APOBEC/AID as a pr
Autor:
Chengcheng Liao, Srikanth Talluri, Shidai Mu, Subodh Kumar, Lakshmi B. Potluri, Jialan Shi, Leutz Buon, Masood A. Shammas, Nikhil C Munshi
Publikováno v:
Blood. 140:9963-9963
Autor:
Nikhil C. Munshi, Srikanth Talluri, Mychell Neptune-Buon, Lakshmi B. Potluri, Masood A. Shammas, Jialan Shi, Subodh Kumar
Publikováno v:
Blood. 136:10-11
Multiple myeloma (MM) is molecularly heterogenous disease with significant genomic instability. It carries number of mutations at diagnosis (median > 7000) and acquires additional changes overtime. With this background, we have evaluated the molecula
Autor:
Rao Prabhala, Masood A. Shammas, Subodh Kumar, Chandraditya Chakraborty, Lakshmi B. Potluri, Jialan Shi, Srikanth Talluri, Jiangning Zhao, Shidai Mu, Leutz Buon, Mychell Neptune-Buon, Mehmet Kemal Samur, Yu-Tzu Tai, Nikhil C. Munshi, Mariateresa Fulciniti, Chengcheng Liao
Publikováno v:
Blood. 136:51-51
Dysregulated homologous recombination (HR) contributes to the acquisition of genomic changes and development of drug resistance over time in multiple myeloma (MM). We have now further investigated the molecular intermediates that may play an importan
Autor:
Masood A. Shammas, Rao Prabhala, Jialan Shi, Subodh Kumar, Leutz Buon, Anil Aktas-Samur, Mehmet Kemal Samur, Srikanth Talluri, Lakshmi B. Potluri, Chandraditya Chakraborty, Nikhil C. Munshi
Publikováno v:
Blood. 136:50-50
Multiple myeloma (MM) is a genomically heterogenous malignancy characterized by a number of copy number alterations (CNA). Moreover, there is a clear evolution of genomic changes that may affect prognosis. To identify the drivers of this inherent gen
Autor:
Lakshmi B. Potluri, Kevin Mills, Chandraditya Chakraborty, Nikhil C. Munshi, Subodh Kumar, Maria Gkotzamanidou, Melinda Day, Srikanth Talluri, Masood A. Shammas, Mychell A. Neptune
Publikováno v:
Blood. 134:4378-4378
Unrepaired DNA double-strand breaks (DSBs) pose a serious threat to genomic stability, potentially leading to the formation of oncogenic mutations, as well as translocations, deletions and amplifications. Almost all multiple myeloma (MM) patients are